| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |